0.009808 0.000000 0.000000 0.000000 0.009808 0.000000 0.000000 0.000000 0.026633 0.00000 0.00000 0.00000 Czabotar, P.E. Westphal, D. Adams, J.M. Colman, P.M. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 8 90.00 90.00 90.00 101.962 101.962 37.548 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Cell(Cambridge,Mass.) CELLB5 0998 0092-8674 152 519 10.1016/J.CELL.2012.12.031 23374347 Bax Crystal Structures Reveal How Bh3 Domains Activate Bax and Nucleate its Oligomerization to Induce Apoptosis. 2013 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100 1 CCD 2011-12-05 ADXV SI(111) SINGLE WAVELENGTH M x-ray 1 0.9537 1.0 MX2 Australian Synchrotron 0.9537 SYNCHROTRON AUSTRALIAN SYNCHROTRON BEAMLINE MX2 19182.711 APOPTOSIS REGULATOR BAX RESIDUES 1-171 YES 1 man polymer 3693.111 BH3-INTERACTING DOMAIN DEATH AGONIST RESIDUES 76-109 1 syn polymer 18.015 water 72 nat water BAX, BCL-2-LIKE PROTEIN 4, BCL2-L-4 BIDBH3, P22 BID, BID, BH3-INTERACTING DOMAIN DEATH AGONIST P P15 BID, BH3-INTERACTING DOMAIN DEATH AGONIST P13, P13 BID, BH3-INTERACTING DOMAIN DEATH AGONIST P11, P11 BID no no MDGSGEQPRGGGPTSSEQIMKTGALLLQGFIQDRAGRMGGEAPELALDPVPQDASTKKLSESLKRIGDELDSNMELQRMI AAVDTDSPREVFFRVAADMFSDGNFNWGRVVALFYFASKLVLKALSTKVPELIRTIMGWTLDFLRERLLGWIQDQGGWDG LLSYFGTPTWQGSS MDGSGEQPRGGGPTSSEQIMKTGALLLQGFIQDRAGRMGGEAPELALDPVPQDASTKKLSESLKRIGDELDSNMELQRMI AAVDTDSPREVFFRVAADMFSDGNFNWGRVVALFYFASKLVLKALSTKVPELIRTIMGWTLDFLRERLLGWIQDQGGWDG LLSYFGTPTWQGSS A polypeptide(L) no no SESQEDIIRNIARHLAQVGDSMDRSIPPGLVNGL SESQEDIIRNIARHLAQVGDSMDRSIPPGLVNGL C polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n HUMAN sample 9606 HOMO SAPIENS 562 ESCHERICHIA COLI 1 2.13 42.3 NONE 1.4 M SODIUM CITRATE, 0.1 M SODIUM CACODYLATE PH 5.75 repository Initial release 1 0 2013-02-13 BAX DOMAIN SWAPPED DIMER IN COMPLEX WITH BAXBH3 BAX DOMAIN SWAPPED DIMER INDUCED BY OCTYLMALTOSIDE BAX DOMAIN SWAPPED DIMER INDUCED BY BIMBH3 WITH CHAPS BAX BH3-IN-GROOVE DIMER (GFP) PDBE Y PDBE 2012-10-04 REL HOH water 9606 HUMAN HOMO SAPIENS sample HOH 2001 3 HOH HOH 2001 A HOH 2002 3 HOH HOH 2002 A HOH 2003 3 HOH HOH 2003 A HOH 2004 3 HOH HOH 2004 A HOH 2005 3 HOH HOH 2005 A HOH 2006 3 HOH HOH 2006 A HOH 2007 3 HOH HOH 2007 A HOH 2008 3 HOH HOH 2008 A HOH 2009 3 HOH HOH 2009 A HOH 2010 3 HOH HOH 2010 A HOH 2011 3 HOH HOH 2011 A HOH 2012 3 HOH HOH 2012 A HOH 2013 3 HOH HOH 2013 A HOH 2014 3 HOH HOH 2014 A HOH 2015 3 HOH HOH 2015 A HOH 2016 3 HOH HOH 2016 A HOH 2017 3 HOH HOH 2017 A HOH 2018 3 HOH HOH 2018 A HOH 2019 3 HOH HOH 2019 A HOH 2020 3 HOH HOH 2020 A HOH 2021 3 HOH HOH 2021 A HOH 2022 3 HOH HOH 2022 A HOH 2023 3 HOH HOH 2023 A HOH 2024 3 HOH HOH 2024 A HOH 2025 3 HOH HOH 2025 A HOH 2026 3 HOH HOH 2026 A HOH 2027 3 HOH HOH 2027 A HOH 2028 3 HOH HOH 2028 A HOH 2029 3 HOH HOH 2029 A HOH 2030 3 HOH HOH 2030 A HOH 2031 3 HOH HOH 2031 A HOH 2032 3 HOH HOH 2032 A HOH 2033 3 HOH HOH 2033 A HOH 2034 3 HOH HOH 2034 A HOH 2035 3 HOH HOH 2035 A HOH 2036 3 HOH HOH 2036 A HOH 2037 3 HOH HOH 2037 A HOH 2038 3 HOH HOH 2038 A HOH 2039 3 HOH HOH 2039 A HOH 2040 3 HOH HOH 2040 A HOH 2041 3 HOH HOH 2041 A HOH 2042 3 HOH HOH 2042 A HOH 2043 3 HOH HOH 2043 A HOH 2044 3 HOH HOH 2044 A HOH 2045 3 HOH HOH 2045 A HOH 2046 3 HOH HOH 2046 A HOH 2047 3 HOH HOH 2047 A HOH 2048 3 HOH HOH 2048 A HOH 2049 3 HOH HOH 2049 A HOH 2050 3 HOH HOH 2050 A HOH 2051 3 HOH HOH 2051 A HOH 2052 3 HOH HOH 2052 A HOH 2053 3 HOH HOH 2053 A HOH 2054 3 HOH HOH 2054 A HOH 2055 3 HOH HOH 2055 A HOH 2056 3 HOH HOH 2056 A HOH 2057 3 HOH HOH 2057 A HOH 2058 3 HOH HOH 2058 A HOH 2059 3 HOH HOH 2059 A HOH 2060 3 HOH HOH 2060 A HOH 2061 3 HOH HOH 2061 A HOH 2062 3 HOH HOH 2062 A HOH 2063 3 HOH HOH 2063 A HOH 2064 3 HOH HOH 2064 A HOH 2065 3 HOH HOH 2065 A HOH 2066 3 HOH HOH 2066 A HOH 2067 3 HOH HOH 2067 A HOH 2068 3 HOH HOH 2068 A HOH 2069 3 HOH HOH 2069 A HOH 2001 3 HOH HOH 2001 C HOH 2002 3 HOH HOH 2002 C HOH 2003 3 HOH HOH 2003 C n 1 1 A n 2 2 A n 3 3 A n 4 4 A n 5 5 A n 6 6 A n 7 7 A n 8 8 A n 9 9 A GLY 10 n 10 GLY 10 A GLY 11 n 11 GLY 11 A GLY 12 n 12 GLY 12 A PRO 13 n 13 PRO 13 A THR 14 n 14 THR 14 A SER 15 n 15 SER 15 A SER 16 n 16 SER 16 A GLU 17 n 17 GLU 17 A GLN 18 n 18 GLN 18 A ILE 19 n 19 ILE 19 A MET 20 n 20 MET 20 A LYS 21 n 21 LYS 21 A THR 22 n 22 THR 22 A GLY 23 n 23 GLY 23 A ALA 24 n 24 ALA 24 A LEU 25 n 25 LEU 25 A LEU 26 n 26 LEU 26 A LEU 27 n 27 LEU 27 A GLN 28 n 28 GLN 28 A GLY 29 n 29 GLY 29 A PHE 30 n 30 PHE 30 A ILE 31 n 31 ILE 31 A GLN 32 n 32 GLN 32 A ASP 33 n 33 ASP 33 A ARG 34 n 34 ARG 34 A ALA 35 n 35 ALA 35 A GLY 36 n 36 GLY 36 A ARG 37 n 37 ARG 37 A n 38 38 A n 39 39 A n 40 40 A n 41 41 A n 42 42 A n 43 43 A n 44 44 A n 45 45 A n 46 46 A n 47 47 A n 48 48 A PRO 49 n 49 PRO 49 A VAL 50 n 50 VAL 50 A PRO 51 n 51 PRO 51 A GLN 52 n 52 GLN 52 A ASP 53 n 53 ASP 53 A ALA 54 n 54 ALA 54 A SER 55 n 55 SER 55 A THR 56 n 56 THR 56 A LYS 57 n 57 LYS 57 A LYS 58 n 58 LYS 58 A LEU 59 n 59 LEU 59 A SER 60 n 60 SER 60 A GLU 61 n 61 GLU 61 A SER 62 n 62 SER 62 A LEU 63 n 63 LEU 63 A LYS 64 n 64 LYS 64 A ARG 65 n 65 ARG 65 A ILE 66 n 66 ILE 66 A GLY 67 n 67 GLY 67 A ASP 68 n 68 ASP 68 A GLU 69 n 69 GLU 69 A LEU 70 n 70 LEU 70 A ASP 71 n 71 ASP 71 A SER 72 n 72 SER 72 A ASN 73 n 73 ASN 73 A MET 74 n 74 MET 74 A GLU 75 n 75 GLU 75 A LEU 76 n 76 LEU 76 A GLN 77 n 77 GLN 77 A ARG 78 n 78 ARG 78 A MET 79 n 79 MET 79 A ILE 80 n 80 ILE 80 A ALA 81 n 81 ALA 81 A ALA 82 n 82 ALA 82 A VAL 83 n 83 VAL 83 A ASP 84 n 84 ASP 84 A THR 85 n 85 THR 85 A ASP 86 n 86 ASP 86 A SER 87 n 87 SER 87 A PRO 88 n 88 PRO 88 A ARG 89 n 89 ARG 89 A GLU 90 n 90 GLU 90 A VAL 91 n 91 VAL 91 A PHE 92 n 92 PHE 92 A PHE 93 n 93 PHE 93 A ARG 94 n 94 ARG 94 A VAL 95 n 95 VAL 95 A ALA 96 n 96 ALA 96 A ALA 97 n 97 ALA 97 A ASP 98 n 98 ASP 98 A MET 99 n 99 MET 99 A PHE 100 n 100 PHE 100 A SER 101 n 101 SER 101 A ASP 102 n 102 ASP 102 A GLY 103 n 103 GLY 103 A ASN 104 n 104 ASN 104 A PHE 105 n 105 PHE 105 A ASN 106 n 106 ASN 106 A TRP 107 n 107 TRP 107 A GLY 108 n 108 GLY 108 A ARG 109 n 109 ARG 109 A VAL 110 n 110 VAL 110 A VAL 111 n 111 VAL 111 A ALA 112 n 112 ALA 112 A LEU 113 n 113 LEU 113 A PHE 114 n 114 PHE 114 A TYR 115 n 115 TYR 115 A PHE 116 n 116 PHE 116 A ALA 117 n 117 ALA 117 A SER 118 n 118 SER 118 A LYS 119 n 119 LYS 119 A LEU 120 n 120 LEU 120 A VAL 121 n 121 VAL 121 A LEU 122 n 122 LEU 122 A LYS 123 n 123 LYS 123 A ALA 124 n 124 ALA 124 A LEU 125 n 125 LEU 125 A SER 126 n 126 SER 126 A THR 127 n 127 THR 127 A LYS 128 n 128 LYS 128 A VAL 129 n 129 VAL 129 A PRO 130 n 130 PRO 130 A GLU 131 n 131 GLU 131 A LEU 132 n 132 LEU 132 A ILE 133 n 133 ILE 133 A ARG 134 n 134 ARG 134 A THR 135 n 135 THR 135 A ILE 136 n 136 ILE 136 A MET 137 n 137 MET 137 A GLY 138 n 138 GLY 138 A TRP 139 n 139 TRP 139 A THR 140 n 140 THR 140 A LEU 141 n 141 LEU 141 A ASP 142 n 142 ASP 142 A PHE 143 n 143 PHE 143 A LEU 144 n 144 LEU 144 A ARG 145 n 145 ARG 145 A GLU 146 n 146 GLU 146 A ARG 147 n 147 ARG 147 A LEU 148 n 148 LEU 148 A LEU 149 n 149 LEU 149 A GLY 150 n 150 GLY 150 A TRP 151 n 151 TRP 151 A ILE 152 n 152 ILE 152 A GLN 153 n 153 GLN 153 A ASP 154 n 154 ASP 154 A GLN 155 n 155 GLN 155 A GLY 156 n 156 GLY 156 A GLY 157 n 157 GLY 157 A TRP 158 n 158 TRP 158 A ASP 159 n 159 ASP 159 A GLY 160 n 160 GLY 160 A LEU 161 n 161 LEU 161 A LEU 162 n 162 LEU 162 A SER 163 n 163 SER 163 A TYR 164 n 164 TYR 164 A PHE 165 n 165 PHE 165 A GLY 166 n 166 GLY 166 A THR 167 n 167 THR 167 A n 168 168 A n 169 169 A n 170 170 A n 171 171 A n 172 172 A n 173 173 A n 174 174 A SER 76 n 1 SER 76 C GLU 77 n 2 GLU 77 C SER 78 n 3 SER 78 C GLN 79 n 4 GLN 79 C GLU 80 n 5 GLU 80 C ASP 81 n 6 ASP 81 C ILE 82 n 7 ILE 82 C ILE 83 n 8 ILE 83 C ARG 84 n 9 ARG 84 C ASN 85 n 10 ASN 85 C ILE 86 n 11 ILE 86 C ALA 87 n 12 ALA 87 C ARG 88 n 13 ARG 88 C HIS 89 n 14 HIS 89 C LEU 90 n 15 LEU 90 C ALA 91 n 16 ALA 91 C GLN 92 n 17 GLN 92 C VAL 93 n 18 VAL 93 C GLY 94 n 19 GLY 94 C ASP 95 n 20 ASP 95 C SER 96 n 21 SER 96 C MET 97 n 22 MET 97 C ASP 98 n 23 ASP 98 C ARG 99 n 24 ARG 99 C SER 100 n 25 SER 100 C ILE 101 n 26 ILE 101 C PRO 102 n 27 PRO 102 C PRO 103 n 28 PRO 103 C GLY 104 n 29 GLY 104 C LEU 105 n 30 LEU 105 C n 31 106 C n 32 107 C n 33 108 C n 34 109 C 0.9404 0.7919 -0.2135 0.9020 -0.0499 -0.0819 -0.0219 0.0928 0.1052 -0.0677 0.0649 0.0988 0.0408 -0.0095 0.0094 0.1821 -0.0289 0.0004 0.2134 0.0608 0.1700 refined 18.9614 -8.1719 41.7997 X-RAY DIFFRACTION X-RAY DIFFRACTION 1 ALL author_and_software_defined_assembly PISA 4 tetrameric 11300 -124.8 16870 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 8_557 -y,-x,-z+5/2 crystal symmetry operation 0.0000000000 0.0000000000 93.8700000000 1 C HOH 2003 D HOH 1 A MET 1 A MET 1 1 Y 1 A ASP 2 A ASP 2 1 Y 1 A GLY 3 A GLY 3 1 Y 1 A SER 4 A SER 4 1 Y 1 A GLY 5 A GLY 5 1 Y 1 A GLU 6 A GLU 6 1 Y 1 A GLN 7 A GLN 7 1 Y 1 A PRO 8 A PRO 8 1 Y 1 A ARG 9 A ARG 9 1 Y 1 A MET 38 A MET 38 1 Y 1 A GLY 39 A GLY 39 1 Y 1 A GLY 40 A GLY 40 1 Y 1 A GLU 41 A GLU 41 1 Y 1 A ALA 42 A ALA 42 1 Y 1 A PRO 43 A PRO 43 1 Y 1 A GLU 44 A GLU 44 1 Y 1 A LEU 45 A LEU 45 1 Y 1 A ALA 46 A ALA 46 1 Y 1 A LEU 47 A LEU 47 1 Y 1 A ASP 48 A ASP 48 1 Y 1 A PRO 168 A PRO 168 1 Y 1 A THR 169 A THR 169 1 Y 1 A TRP 170 A TRP 170 1 Y 1 A GLN 171 A GLN 171 1 Y 1 A GLY 172 A GLY 172 1 Y 1 A SER 173 A SER 173 1 Y 1 A SER 174 A SER 174 1 Y 1 C VAL 106 B VAL 31 1 Y 1 C ASN 107 B ASN 32 1 Y 1 C GLY 108 B GLY 33 1 Y 1 C LEU 109 B LEU 34 1 Y 1 A A O O HOH HOH 2049 2050 2.08 1 A A O O THR HOH 167 2068 2.14 1 A A NE O ARG HOH 34 2011 2.18 1 A A O O HOH HOH 2017 2062 2.16 1_555 8_557 1 A ASN 73 -65.21 98.98 1 A SER 87 -116.73 69.14 41.17 0.7605 0.0000 0.0000 0.7605 0.0000 -1.5210 0.2270 0.1763 0.1790 2.206 50.981 522 10428 5.0 99.78 0.32 1 2.00 MOLECULAR REPLACEMENT 21.97 0.86 1.10 BAX DOMAIN SWAPPED DIMER INDUCED BY OCTYLMALTOSIDE ML FLAT BULK SOLVENT MODEL 61.640 0.376 2.206 50.981 72 1455 0 0 1383 0.008 1407 0.973 1894 14.018 524 0.064 208 0.004 245 0.3313 0.2437 2.4280 126 2388 99.00 0.2724 0.2023 2.7793 128 2438 100.00 0.2579 0.1788 3.5015 130 2474 100.00 0.1771 0.1529 50.9946 138 2606 100.00 34.53 2.21 51.00 4BD2 10428 -3.0 0.22 1 9.66 13.9 99.8 1.50 2.21 2.43 2.02 1 14.1 98.8 refinement PHENIX (PHENIX.REFINE) data reduction XDS data scaling XDS phasing PHASER APOPTOSIS REGULATOR BAX, BH3-INTERACTING DOMAIN DEATH AGONIST Bax domain swapped dimer in complex with BidBH3 1 N N 2 N N 3 N N 3 N N A SER 15 A SER 15 HELX_P A ARG 37 A ARG 37 1 1 23 A ASP 53 A ASP 53 HELX_P A ASN 73 A ASN 73 1 2 21 A ASN 73 A ASN 73 HELX_P A VAL 83 A VAL 83 1 3 11 A SER 87 A SER 87 HELX_P A PHE 100 A PHE 100 1 4 14 A ASN 106 A ASN 106 HELX_P A LEU 148 A LEU 148 1 5 43 A LEU 148 A LEU 148 HELX_P A GLN 155 A GLN 155 1 6 8 A TRP 158 A TRP 158 HELX_P A PHE 165 A PHE 165 1 7 8 C SER 76 B SER 1 HELX_P C MET 97 B MET 22 1 8 22 C ASP 98 B ASP 23 HELX_P C SER 100 B SER 25 5 9 3 APOPTOSIS APOPTOSIS, PROGRAMMED CELL DEATH, BCL-2 FAMILY. C ILE 101 B ILE 26 1 C PRO 102 B PRO 27 0.62 BAX_HUMAN UNP 1 Q07812 BID_HUMAN UNP 2 P55957 1 171 4BD2 1 171 Q07812 A 1 1 171 76 109 4BD2 76 109 P55957 C 2 1 34 1 expression tag GLY 172 4BD2 A Q07812 UNP 172 1 expression tag SER 173 4BD2 A Q07812 UNP 173 1 expression tag SER 174 4BD2 A Q07812 UNP 174 1 CYS engineered mutation SER 62 4BD2 A Q07812 UNP 62 62 1 CYS engineered mutation SER 126 4BD2 A Q07812 UNP 126 126 96 P 43 21 2